Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up

The manufacture of recombinant therapeutics is a fastest-developing section of therapeutic pharmaceuticals and presently plays a significant role in disease management. Yeasts are established eukaryotic host for heterologous protein production and offer distinctive benefits in synthesising pharmaceu...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhavan, Aravind, Arun, K. B., Sindhu, Raveendran, Krishnamoorthy, Jayaram, Reshmy, R., Sirohi, Ranjna, Pugazhendi, Arivalagan, Awasthi, Mukesh Kumar, Szakacs, George, Binod, Parameswaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246677/
https://www.ncbi.nlm.nih.gov/pubmed/34193127
http://dx.doi.org/10.1186/s12934-021-01617-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246677/
https://www.ncbi.nlm.nih.gov/pubmed/34193127
http://dx.doi.org/10.1186/s12934-021-01617-z

Ejemplares similares